Home » Therapeutic Clinical Trials Experience And Expertise » Vaccine Study CRO Services

Vaccine Study CRO Services

Request a quote

PHARMExcel provides specialist Vaccines CRO Services for sponsors conducting vaccine clinical trials across infectious diseases and selected oncology settings. We work with biotechs, medtech companies, charities and NHS or academic sponsors to help deliver vaccine studies that are scientifically robust, operationally realistic and aligned with the needs of healthy volunteers, patient populations, investigators and specialist sites.

Our services are focused on the clinical trial stage, helping sponsors translate vaccine programmes into well-governed human studies through tailored regulatory strategy, oversight and hands-on clinical operations. This includes Phase I, Phase II and Phase IIa vaccine studies where careful protocol planning, safety oversight, site feasibility and regulatory engagement are essential.

Vaccine clinical trials explained

Vaccine clinical trials are designed to evaluate safety, tolerability, immune response and clinical performance in carefully defined populations. Depending on the indication, these studies may involve healthy volunteers, infectious disease settings or diagnosed oncology populations where therapeutic vaccine approaches are being assessed. Trial design must therefore balance scientific rigour with practical delivery in real-world clinical environments.

Vaccine studies often involve close safety monitoring, structured visit schedules, precise handling requirements and detailed regulatory documentation. In some programmes, timelines may be compressed due to public health priorities or urgent clinical need, making clear governance and realistic site planning especially important.

Specialised expertise across vaccine and infectious disease research

Vaccine trials can be complex because they sit at the intersection of immunology, safety oversight, operational control and regulatory scrutiny. PHARMExcel helps sponsors navigate these complexities at the clinical trial stage, providing governance and oversight across protocols, specialist site pathways and study delivery.

Our teams can support vaccine studies in infectious diseases as well as oncology vaccine programmes, where patient populations, safety considerations and trial pathways may differ significantly. We understand that these studies require careful alignment between sponsor expectations, regulatory strategy and the practical realities of site-based delivery.

"PHARMExcel has been a pleasure to work with, responsive and flexible."

Professor Saul Faust (OBE), Director, NIHR Southampton Clinical Research Facility, Covid Booster Study

Regulatory strategy and oversight for vaccine trials

PHARMExcel does not develop vaccines in the laboratory as our role begins when a sponsor is preparing to move into human clinical trials and needs the right governance and oversight, regulatory strategy and clinical delivery modality. We help sponsors prepare the regulatory packages needed to enter clinical studies and support engagement with the relevant authorities throughout the study lifecycle.

This includes helping sponsors shape clinical trial applications, prepare supporting documentation and manage discussions with regulators in a way that reflects the specific requirements of vaccine research. For many vaccine programmes, this regulatory leadership is central to moving efficiently from preclinical evidence into compliant clinical trial delivery.

Clinical operations and vaccine trial delivery

PHARMExcel provides governance and manages the full cycle of the vaccine trial delivery, including study start-up, site selection, monitoring, project management and close out. We work with sponsors to identify the most appropriate centres, investigators and delivery pathways for each study, based on population, indication and protocol complexity.

Our teams focus on ensuring that trial processes are practical and clearly understood by sites, particularly where studies involve healthy volunteer enrolment, detailed safety follow-up or multiple dose schedules. We do not directly recruit participants, but we help sponsors establish realistic, site-led screening and enrolment pathways and maintain operational control throughout the study lifecycle.

Safety monitoring, data oversight and study governance

Vaccine trials depend on clear safety oversight and reliable data capture. PHARMExcel provides the structured oversight, monitoring and documentation frameworks required to safeguard protocol requirements, ensure consistent safety reporting and generate high-quality data across sites.This is especially important where studies involve reactogenicity monitoring, repeat visits, safety follow-up or time-sensitive reporting obligations.

Our role is to help ensure that vaccine studies remain compliant, audit ready and operationally realistic, with oversight structures that reflect the pace and complexity of the protocol. We work closely with sponsors and investigators to maintain study integrity without creating unnecessary burden for sites or participants. Our work on the Covid Vaccine study demonstrates this approach in practice, from protocol governance through to site-level monitoring and close-out.

"The support from PHARMExcel has been extremely high quality. This includes all aspects of trial development, management and monitoring, that was also evidenced by a recent sponsor audit. We look forward to working with PHARMExcel going forward."

Tom Fletcher, CST-6 Candidate Chief Investigator Director Global Health Trials Unit, Liverpool School of Tropical Medicine

Specialist site, public health readiness and patient pathways

Vaccine studies often depend on the right network of sites, investigators and referral pathways, particularly where timelines are tight or where the protocol needs to align with public health or specialist treatment settings. PHARMExcel brings strategic direction and operational clarity to this process by helping sponsors identify the most appropriate sites and study pathways for their programme.

This is particularly relevant in infectious disease vaccine research and in oncology vaccine studies, where patient pathways, safety considerations and visit schedules may differ significantly. Our role is to help sponsors plan realistic delivery strategies that reflect site capability, participant burden and the operational realities of vaccine research in the UK and wider clinical setting.

Partner with PHARMExcel for vaccines CRO services

Sponsors choose PHARMExcel because we combine therapeutic understanding, agile clinical operations and a quality-driven approach to trial delivery. As a smaller CRO, we offer direct access to senior staff, continuity of team and the flexibility to shape our involvement around the needs of the study, whether that means full service vaccine CRO support or focused assistance with specific parts of the trial.

Our aim is to reduce operational burden, support regulatory readiness and help sponsors deliver high-quality vaccine clinical trials that are feasible in practice as well as robust on paper. For organisations looking for a collaborative and responsive CRO partner in vaccine research, PHARMExcel provides practical expertise grounded in real-world clinical trial delivery.

Vaccine study FAQs

What types of vaccine studies can PHARMExcel support?

PHARMExcel can support vaccine clinical trials in infectious diseases and selected oncology settings, including studies involving healthy volunteers as well as diagnosed patient populations where appropriate. Our role is focused on the clinical trial stage, where governance, regulatory strategy, specialist site coordination and recruitment are central to successful delivery.

Does PHARMExcel develop vaccines?

No. PHARMExcel does not undertake laboratory development or preclinical vaccine research. Our role begins when a sponsor is preparing to enter human clinical trials and needs regulatory guidance, governance and operational oversight to deliver those studies effectively.

Which phases of vaccine trials can PHARMExcel support?

PHARMExcel supports vaccine studies at the clinical trial stage, particularly Phase I, Phase II and Phase IIa research where close safety oversight, specialist site coordination and regulatory engagement are essential.

How does PHARMExcel approach recruitment in vaccine trials?

PHARMExcel does not directly recruit participants. Instead, we provide governance and oversight of site-led screening and enrolment by helping sponsors identify suitable sites, define realistic eligibility pathways and work with investigators who understand the local study population and site processes.

How does PHARMExcel support regulatory requirements for vaccine trials?

We support sponsors with clinical trial applications, safety reporting and wider documentation needed to progress vaccine studies in line with regulatory expectations. We also help sponsors prepare for and manage discussions with regulators during the clinical trial stage.

Why choose PHARMExcel as a vaccines CRO?

Sponsors choose PHARMExcel for our responsive, quality-led approach to clinical trial delivery. As a smaller CRO, we provide direct access to senior staff, continuity of team and practical oversight across the trial lifecycle, helping vaccine studies remain feasible, compliant and well governed.